AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2010
Jun 12, 2010
35599_dirs_2010-06-11_76228d0f-6e2b-4c93-8fa9-6bf9cf4a1efc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2010-06-08
Reporting Person: Butts Robert W (Director, Chairman of Board, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 41504000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Warrants | $0.08 | 2015-04-30 | Common Stock (41504000) | Direct |
Footnotes
F1: Warrants are not registered and not excerciseable until October 31, 2010.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20